Most corporate innovation programs fail not because of bad ideas, but because of organizational conditions that make good ideas impossible to execute. After 25 years working with industrial and B2B companies on innovation strategy, I see nine specific blockers that account for the vast majority of failures. They are not mysterious. They are structural, predictable, and almost always fixable.
The problem is that most organizations try to fix the symptoms — the ideas that are not working, the teams that seem unmotivated, the workshops that produce no results — instead of the underlying conditions. This guide maps the nine blockers across the three levers of the innovation readiness framework, with a diagnostic question for each one so you can identify which ones apply to your organization.
Stop diagnosing symptoms. Find the real blocker.
In a 30-minute strategy call, I will map which of these nine blockers is holding back innovation at your organization — and which one to fix first. Based on patterns from 50+ companies over 25 years.
Lever 1: Leadership support blockers
These are the blockers that live at the top of the organization. They are also the most important to fix first, because every other blocker depends on leadership authority to address.
Blocker 1: No innovation strategy beyond “be more innovative”
Leadership announces innovation as a strategic priority. But when you ask what that means specifically — which business models to explore, which customer segments to develop, what the balance should be between incremental improvements and transformative bets — the answers are vague or missing.
“Be more innovative” is not an innovation strategy. It is a wish. Without a clear direction, every initiative claims to be innovative and none of them are actually exploration. R&D projects get relabeled as innovation. Process improvements get presented as transformation. The budget gets absorbed by incremental work because there is no strategic framework to evaluate what counts as exploration.
This pattern is particularly common in manufacturing and industrial companies where “innovation” has historically meant product improvement and cost reduction. These are valuable activities, but they are exploitation of the existing business, not exploration of new opportunities. When the strategy does not distinguish between the two, exploitation always wins because it has shorter payback cycles and clearer financial metrics.
Diagnostic question: Can your leadership team name two or three specific exploration bets — new business models, new customer segments, or new revenue streams — that are distinct from the core business roadmap? If not, you have this blocker.
Blocker 2: No protected innovation budget
There is an innovation budget on paper. The question is whether it survives the first reallocation pressure.
I see this pattern regularly: a company allocates €300.000 for innovation in January. By March, raw material costs spike. A major customer order requires extra production capacity. The finance team needs to find savings. The innovation budget is the first line item that disappears, because it has no committed output in the current quarter and every other budget does.
A budget that leadership can reallocate whenever the core business needs it is not an innovation budget. It is discretionary spending with an optimistic name. The test is simple: when was the last time the core business needed resources and the innovation budget was not touched?
Protected means protected at the level where the reallocation decisions happen — typically the board or CFO. Not a commitment that the head of innovation can defend in a department meeting, but a structural commitment that survives quarterly pressure from above.
Resources also means people, not just money. “We have given three people 20% of their time for innovation” is not a meaningful resource commitment when those same three people have utilization targets in their primary role. Protected innovation resources mean dedicated time and headcount, insulated from operational demand.
Diagnostic question: Has your innovation budget survived intact through at least two consecutive quarters where the core business was under pressure? If not, you have this blocker.
Blocker 3: No portfolio discipline — all budget goes to incremental improvement
Most organizations I work with do not have a formal innovation portfolio. They have a list of R&D projects, which is not the same thing.
Portfolio discipline means consciously balancing efficiency innovation, sustaining innovation, and transformative innovation. In practice, this means leadership can look at their innovation spend and say: “This percentage goes to exploiting the current business more efficiently. This percentage goes to extending the current business. This percentage goes to exploring genuinely new business models.” Without that discipline, the portfolio defaults to incremental: it is easier to fund an incremental project because the business case is clearer, the risk is lower, and the timeline is shorter.
The research behind The Invincible Company is consistent: companies that survive long-term maintain a conscious balance between exploit and explore. Companies that let the portfolio drift entirely toward exploitation eventually face a competitiveness cliff when the market shifts and they have no exploration pipeline. In manufacturing companies, this drift toward exploitation is almost universal. More than 90% of what gets called “innovation investment” typically goes to efficiency and product line extensions.
Innovation portfolio management means reviewing what is in the exploration pipeline, making active decisions about what to fund and what to stop, and protecting the balance against the gravitational pull of exploitation. This is a governance discipline, not an attitude. It requires a defined process, a regular review cadence, and leadership that makes explicit portfolio decisions.
Diagnostic question: Can your leadership team describe the balance between exploit and explore in your current innovation investment? Has any project in the explore category been formally stopped based on evidence in the past 12 months? If not, you have this blocker.
Lever 2: Organizational design blockers
These blockers sit in the structural choices organizations make: where innovation reports, who has access to what, and what gets rewarded.
Blocker 4: Innovation has no power or legitimacy
Where does innovation sit in your organization? Who does the innovation leader report to? How many decisions can they make without escalation?
In many industrial companies, innovation sits inside R&D or engineering. The innovation manager is two or three levels below the C-suite. They have a mandate to “drive innovation” but no budget authority, no hiring authority, and no power to override decisions from business units that block innovation requests.
The result is predictable: the innovation function becomes a facilitator of workshops rather than a driver of results. They run design sprints, organize innovation days, and build roadmaps that nobody acts on, because they have no authority to make the organizational changes that would enable the roadmap. Everyone agrees innovation is important. Nobody gives it the authority it needs to actually do anything.
This is a structural problem, not a people problem. Putting a talented person in a structurally powerless role produces the same result regardless of who the person is.
Diagnostic question: What is the highest-value decision your innovation leader can make without getting it approved by someone who is not focused on innovation? If the answer is “none” or “very small things,” you have this blocker.
Blocker 5: The bridge to the core business is blocked
Innovation teams need access to the core business: engineering expertise, production capacity, customer relationships, distribution channels, operational knowledge. This is the structural advantage established companies have over startups. A manufacturer that can give its innovation team direct access to a production facility, a materials lab, and customer engineering contacts can test physical prototypes in ways no startup can match.
But that access is only real if the organizational structure makes it possible. When every request from the innovation team to use production resources requires a formal work order, competes with customer orders for scheduling priority, and takes four months to approve, the bridge is blocked. The advantage of being an established company disappears.
I see this pattern regularly: the innovation team theoretically has access to everything the core business can offer. In practice, the access requires approvals that take longer than the experiments themselves. The innovation manager who says “we could have tested that assumption in three weeks if we had access to one engineer for two days” is not complaining about resources. They are describing a structural blocker that prevents the organization from using its own assets.
Diagnostic question: How long does it take for your innovation team to get access to an engineer, a production line, or a key customer contact for a time-sensitive test? If the answer is measured in months rather than days, you have this blocker.
Blocker 6: The incentive system punishes risk-taking
This is, in my experience, the single most damaging innovation culture blocker in industrial and manufacturing companies. And it is the one that leadership is most reluctant to address because it requires changing systems they spent years building.
The incentive structure of most industrial companies rewards execution excellence. Plant managers are measured on uptime, efficiency, and quality. Engineers are rewarded for on-time delivery and specification compliance. Sales managers are measured on revenue from the existing product portfolio. These are appropriate metrics for running the current business. They are poison for innovation.
Volunteering for an innovation project in this environment is career risk with zero upside. If the project succeeds, the commercial team that closes the deal gets the credit. If the project fails, the engineer who spent six months on it has six months of underperformance on their KPIs. The rational choice — from the perspective of a manager who understands the incentive system — is to stay in the core business and let someone else take the innovation risk.
As Gary Pisano argued in Harvard Business Review, innovative cultures require tolerance for failure and intolerance for incompetence. Most industrial companies have the opposite: zero tolerance for operational failure of any kind and high tolerance for organizational dysfunction. The incentive structure makes the cultures incompatible.
Fixing this requires creating a separate evaluation framework for people working on innovation: success criteria defined around learning milestones, assumption testing, and customer discovery — not delivery metrics. This is not a bonus on top of the existing system. It is a fundamentally different way of measuring contribution for a fundamentally different kind of work.
Diagnostic question: What happens to the career of a manager who spends 12 months on an innovation project that gets cancelled based on evidence? If the honest answer is “nothing good,” you have this blocker.
Lever 3: Innovation practice blockers
These blockers live in how innovation work actually gets done: the tools, processes, and skills the organization has or lacks.
Blocker 7: No explore tools — only exploit methodologies
Most industrial companies are very good at exploit tools: lean manufacturing, Six Sigma, Kaizen, stage-gate project management. These are powerful, proven methods for improving the efficiency and quality of the current business.
They are the wrong tools for exploration.
Lean manufacturing optimizes a known process. It cannot help you figure out whether there is a customer for a new business model. Six Sigma reduces defects in a defined system. It cannot help you test an assumption about a new market. Stage-gate manages projects where the market is known and the technology is proven. It kills exploratory projects by demanding financial certainty before any customer evidence exists.
The tools for exploration are different: the Business Model Canvas and Value Proposition Canvas for designing new business models, customer discovery methods for validating assumptions, and experiment design for testing business ideas systematically before committing to development. These tools require different skills, different mindsets, and different organizational processes than exploit tools.
In most manufacturing companies, explore tools exist in pockets: someone attended a design thinking workshop, a team used a canvas once. Organizational adoption — where these tools are integrated into how innovation work actually gets done — is rare.
Diagnostic question: Can you name three people in your organization who regularly use business model design and experiment design tools in their daily work? Not in workshops. In daily work. If you cannot, you have this blocker.
Blocker 8: The process demands certainty before you have any evidence
The standard innovation process in most industrial companies is some version of stage-gate: idea submission, concept review, feasibility study, business case, development approval, launch. Every stage requires more rigorous documentation and more concrete financial projections.
Stage-gate was designed for sustaining innovation where the market is known and the technology is proven. You are extending an existing product line, entering an adjacent market, or improving a known process. In those cases, the certainty stage-gate demands is achievable.
For transformative innovation — where you are exploring a new business model, a new customer segment, or a new technology platform — stage-gate demands certainty before you have any evidence to support it. The business case for a genuinely new idea is a work of fiction at the concept stage. Nobody knows the market size. Nobody knows the cost to serve. Nobody knows the conversion rate. The stage-gate process selects for projects that sound credible in a meeting room, not projects that have been validated with customers.
The result: the most promising exploratory ideas get filtered out by a process designed for incremental innovation, while incremental projects advance because they have the historical data to fill in the business case template. The organization innovates less boldly, year over year, because the process rewards incrementalism.
Diagnostic question: At what stage does your innovation process require a financial forecast for a new project? If the answer is “before we have talked to any customers,” you have this blocker.
Blocker 9: No innovation skills — technical competence is deep, innovation competence is absent
Manufacturing and industrial companies hire for technical excellence. Engineering, production management, quality control, supply chain, maintenance — these are difficult, specialized skills, and successful industrial companies develop them to a high level.
Innovation requires additional skills that are entirely different: customer discovery, assumption mapping, experiment design, business model thinking, pivot logic. These are not extensions of technical competence. They are a different capability set that requires different training and different practice.
Most manufacturers expect operational managers to develop innovation skills on the side. An R&D engineer who attended two workshops is now supposed to lead customer discovery. A plant manager who read a book about lean startup is supposed to run portfolio experiments. The expectation is unrealistic and the results match the expectation.
The gap shows up most clearly when I ask a leadership team: “Who in this organization has deep experience designing and running business experiments?” Not people who have attended workshops. People who have designed an experiment, defined the success criteria, run the test, interpreted the results, and made a decision based on the evidence. In most industrial companies, the room goes quiet.
Technical competence is a competitive asset. Innovation competence is an organizational investment. Both require explicit development. Companies that treat innovation skills as a free add-on to existing roles are making a structural choice to remain technically strong and strategically vulnerable.
Diagnostic question: Who in your organization has led a complete experiment cycle — hypothesis, test design, execution, interpretation, and decision — in the past six months? If you cannot name two people, you have this blocker.
Which blocker to fix first
You cannot address all nine blockers at once, and trying to address them all simultaneously produces no real change anywhere. The sequence matters.
Fix leadership support first, and specifically fix the resource allocation blocker before anything else. Until your leadership team makes a credible, structurally protected commitment to innovation resources, no other fix sticks. Organizational design changes require leadership authority to implement. Incentive changes require leadership approval. Investment in innovation practice requires leadership budget.
After resource commitment is established, address the incentive system. This is the most common organizational design blocker and the one with the widest effect. When you change what gets rewarded, you change what people actually do. Everything else follows from that.
After the incentive structure is addressed, invest in innovation practice: tools, processes, skills. This is the right sequence, not the reverse. Investing in tools and training before fixing the incentive system and resource commitment is guaranteed to produce disappointing results. The tools are fine. The conditions for using them are not.
For a facilitated approach to diagnosing which blockers are most acute in your organization, see How to run an innovation readiness workshop.
To score your organization on each of these blockers systematically, see how to run an innovation culture assessment.
For a deep dive into what leadership support actually requires in practice, see Innovation leadership: what it actually takes.
